Anti-SUPT20H Antibody Picoband® Cy3 Vervoeging

Predicted to enable transcription coregulator activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within positive regulation of gluconeogenesis and positive regulation of transcription by RNA polymerase II. Part of SAGA-type complex.

SUPT20H; C13orf19; FAM48A; FP757; Transcription factor SPT20 homolog; p38-interacting protein; p38IP

SUPT20H

55578

Q8NEM7

Human, Rat

No cross-reactivity with other proteins

E.coli-derived human SUPT20H recombinant protein (Position: M1-Q713) .

Flow Cytometry

Immunogen affinity purified.

Liquid

1. Schmidt, U., Fiedler, U., Pilarsky, C. P., Ehlers, W., Fussel, S., Haase, M., Faller, G., Sauter, G., Wirth, M. P. Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1. Prostate 47: 91-101, 2001. 2. Zohn, I. E., Li, Y., Skolnik, E. Y., Anderson, K. V., Han, J., Niswander, L. p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 125: 957-969, 2006.

At -20 ̊C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

86 kDa

6

SPT20 homolog, SAGA complex component

Transcription factor SPT20 homolog

Rabbit IgG

Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3.